KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Goodwill (2019 - 2025)

Historic Goodwill for Guardant Health (GH) over the last 7 years, with Q3 2025 value amounting to $3.3 million.

  • Guardant Health's Goodwill changed 0.0% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.3 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Guardant Health's Goodwill stood at $3.3 million, which was down 0.0% from $3.3 million recorded in Q2 2025.
  • Guardant Health's Goodwill's 5-year high stood at $3.3 million during Q1 2021, with a 5-year trough of $3.3 million in Q1 2021.
  • For the 5-year period, Guardant Health's Goodwill averaged around $3.3 million, with its median value being $3.3 million (2021).
  • Data for Guardant Health's Goodwill shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
  • Over the past 5 years, Guardant Health's Goodwill (Quarter) stood at $3.3 million in 2021, then changed by 0.0% to $3.3 million in 2022, then changed by 0.0% to $3.3 million in 2023, then changed by 0.0% to $3.3 million in 2024, then changed by 0.0% to $3.3 million in 2025.
  • Its Goodwill stands at $3.3 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.3 million for Q1 2025.